Covered recipient · General Payments record
VICTORIA L BLAIR
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$3,704.99
- Reported across 193 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $777.77 | 34 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $228.22 | 13 |
| Amgen Inc. | $220.33 | 8 |
| Edwards Lifesciences Corporation | $96.62 | 1 |
| Vanda Pharmaceuticals Inc. | $51.50 | 2 |
| Corcept Therapeutics | $47.45 | 3 |
| Celgene Corporation | $46.37 | 2 |
| Lilly USA, LLC | $21.75 | 1 |
| GlaxoSmithKline, LLC. | $17.41 | 1 |
| Novo Nordisk AS | $17.28 | 1 |
| ITI, Inc. | $16.14 | 1 |
| Inspire Medical Systems, Inc. | $14.70 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (34)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $32.04 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106770152 | CMS |
| ABBVIE INC. | $10.60 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106770155 | CMS |
| ABBVIE INC. | $34.84 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106770159 | CMS |
| ABBVIE INC. | $20.90 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106770162 | CMS |
| ABBVIE INC. | $8.45 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106770166 | CMS |
| ABBVIE INC. | $14.41 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106770170 | CMS |
| ABBVIE INC. | $25.10 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106770174 | CMS |
| ABBVIE INC. | $25.26 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106770177 | CMS |
| ABBVIE INC. | $15.19 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106770181 | CMS |
| ABBVIE INC. | $4.24 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106770185 | CMS |
| ABBVIE INC. | $6.36 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106770188 | CMS |
| ABBVIE INC. | $24.03 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106770191 | CMS |
| ABBVIE INC. | $6.80 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106770197 | CMS |
| Amgen Inc. | $11.27 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117204592 | CMS |
| Amgen Inc. | $124.99 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117508810 | CMS |
| Amgen Inc. | $17.78 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117204594 | CMS |
| Amgen Inc. | $12.68 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117204596 | CMS |
| Amgen Inc. | $13.59 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117204598 | CMS |
| Amgen Inc. | $10.43 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117204600 | CMS |
| Amgen Inc. | $15.50 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117508808 | CMS |
| Amgen Inc. | $14.09 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117204602 | CMS |
| Celgene Corporation | $32.69 | 02/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101093007 | CMS |
| Celgene Corporation | $13.68 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101093019 | CMS |
| Corcept Therapeutics | $13.71 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117754822 | CMS |
| Corcept Therapeutics | $13.16 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117754892 | CMS |
| Corcept Therapeutics | $20.58 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117754926 | CMS |
| Edwards Lifesciences Corporation | $96.62 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138827636 | CMS |
| GlaxoSmithKline, LLC. | $17.41 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116512079 | CMS |
| Inspire Medical Systems, Inc. | $14.70 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148135247 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $16.14 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143377657 | CMS |
| Lilly USA, LLC | $21.75 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135971162 | CMS |
| Novo Nordisk Inc | $17.28 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100506669 | CMS |
| Vanda Pharmaceuticals Inc. | $16.58 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133931828 | CMS |
| Vanda Pharmaceuticals Inc. | $34.92 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133931830 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.